2015 American Transplant Congress
Changes in Acceptances Patterns Under Share 35
University of Texas HSC, San Antonio, TX; UNOS, Richmond, VA.
The Share 35 policy was implemented June 2013 with intent of directing to livers to the sickest patients with the highest mortality and presumably shortest…2015 American Transplant Congress
High Tolerability With Sofosbuvir-Based Direct-Acting Antiviral Therapy in Liver Transplant Recipients With Recurrent Hepatitis C
Background: Reports on efficacy, safety, and tolerability of sofobuvir-based antiviral regimens in liver transplant recipients with recurrent hepatitis C are limited. Methods: We performed a…2015 American Transplant Congress
Plasmapharesis, Intravenous Immunoglobulin and Rituximab Successfully Treat Recurrent Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) After Liver Transplantation
Background:Allo-immune mediated BSEP dysfunction may occur after liver transplantation in PFIC2 patients leading to a PFIC2 like phenotype. The IgG antibodies are reactive toward a…2015 American Transplant Congress
Pre-Liver Transplant Urinary Proteome Analysis Does Not Predict Development of Chronic Kidney Disease After Transplantation
Background and aims: Chronic kidney disease (CKD) is a common complication after liver transplantation. Kidney biopsies cannot be easily performed before liver transplantation to predict…2015 American Transplant Congress
Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Background: The most common pathogens seen in early post LT intraabdominal and bloodstream infection are enterococci, staphylococci and aerobic gram negative bacilli and perioperative prophylaxis…2015 American Transplant Congress
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report
1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO.
INTRODUCTION: Discrepancy between demand (end stage organ disease) and supply (organs) remains one of the limiting factors in solid organ transplantation and underlies the dynamics…2015 American Transplant Congress
ABO-Incompatible Liver Transplantation for Severe Hepatitis B Patients
Objectives: Effect of ABO-incompatible liver transplantation on severe hepatitis B (SHB) patients is still unclear. Herein, we described 22 successful cases of patients with SHB…2015 American Transplant Congress
The Negative Impact of Hepatitis C Infection (HCV+) On Orthotopic Liver Transplantation (OLT) for Hepatocellular Carcinoma (HCC)
Background: HCC is commonly associated with viral infections such as HCV & HBV.Aim: To determine whether Hepatitis viral status has impact on survival after OLT…2015 American Transplant Congress
Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates
Liver failure is the most common cause of non-AIDS related death among HIV+ patients, primarily due to high prevalence of co-infection with hepatitis C (HCV)…2015 American Transplant Congress
Effective Long-Term Prophylaxis against De Novo Hepatitis B With Hepatitis B Vaccination in Pediatric Recipients of HbcAb-Positive Liver Grafts
Department of Surgery, Samsung Medical Center, Seoul, Korea.
Background) Controversy still exists concerning the use of livers from hepatitis B surface antigen-negative (HBsAg-)/hepatitis B core antibody-positive (HBcAb+) donors for liver transplantation (LT). We…
- « Previous Page
- 1
- …
- 166
- 167
- 168
- 169
- 170
- …
- 180
- Next Page »